Scientific Papers

Scientific Papers

NF1 Specific

Clinical and genetic aspects of neurofibromatosis 1

Jett, Kimberly BSc1; Friedman, Jan M. MD, PhD1,2

Primary Care for Patients with Neurofibromatosis 1

Leigh Hart, RN, CCRN, PhD

Health Supervision for Children with Neurofibromatosis

Joseph H. Hersh and Committee on Genetics Journal of the American Academy of Pediatrics

Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients.

Marge Lammert, Victor-Felix Mautner, and Lan Kluwe

Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in Patients with Neurofibromatosis Type 1

Ruth Lim, Diego Jaramillo, Tina Young Poussaint, Yuchiao Chang and Bruce Korf.

Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)

Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR.

Practical Genetics: Neurofibromatosis 1

Rosalie E Ferner, Department of Neurology, Guy’s and St Thomas’ Hospitals, London, UK

NF2 Specific

Neurofibromatosis Type 2 (NF2): A clinical and molecular view

D. Gareth R. Evans

Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation

Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW

Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib

Plotkin SR, Halpin CF, McKenna MJ, Batchelor TT, Loeffler JS, Barker FG

Merlin Is a Potent Inhibitor of Glioma Growth

Lau YKI, Murray LB, Houshmandi SS, Xu Y, Gutmann DH, Yu Q

Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates

Mathieu D et al.

Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients

Scott R. Plotkin, M.D., Ph.D., Caroline C. O’Donnell, B.A., R.N., William T. Curry Jr., M.D., Catherine M. Bove, M.Ed., A.P.N.G., Mia MacCollin, M.D., and Fabio P. Nunes, M.D.

Participating in Research

People with NF play an important role in the development of new treatments of neurofibromatosis by participating in clinical trials. If you are interested in participating in a trial, please visit our page on the subject.